Literature DB >> 27257154

Life-threatening hypocalcaemia associated with denosumab in advanced chronic kidney disease.

J P Killen1, K Yong1, G Luxton1, Z Endre1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27257154     DOI： 10.1111/imj.13097

Source DB:  PubMed          Journal:  Intern Med J        ISSN： 1444-0903            Impact factor:   2.048


× No keyword cloud information.
  3 in total

1.  Hypocalcemia and bone mineral density changes following denosumab treatment in end-stage renal disease patients: a meta-analysis of observational studies.

Authors:  C Thongprayoon; P Acharya; C Acharya; J Chenbhanich; T Bathini; B Boonpheng; K Sharma; K Wijarnpreecha; P Ungprasert; M L Gonzalez Suarez; W Cheungpasitporn
Journal:  Osteoporos Int       Date:  2018-04-30       Impact factor: 4.507

Review 2.  Hypocalcaemia in patients with prostate cancer treated with a bisphosphonate or denosumab: prevention supports treatment completion.

Authors:  Jean-Jacques Body; Roger von Moos; Daniela Niepel; Bertrand Tombal
Journal:  BMC Urol       Date:  2018-09-20       Impact factor: 2.264

3.  Severe, Symptomatic Hypocalcemia due to Denosumab Administration: Treatment and Clinical Course.

Authors:  Jarred Strickling; Michael J Wilkowski
Journal:  Case Rep Nephrol Dial       Date:  2019-04-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.